DriverDB: An exome sequencing database for cancer driver gene identification

Nucleic Acids Research

Volumn 42, Issue D1, 2014, Pages

  Cheng, Wei Chung ^a,b   Chung, I Fang ^b   Chen, Chen Yang ^b   Sun, Hsing Jen ^b   Fen, Jun Jeng ^b,c   Tang, Wei Chun ^b   Chang, Ting Yu ^b   Wong, Tai Tong ^a,b   Wang, Hsei Wei ^b,d  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLIENT SERVER APPLICATION; COMPUTER INTERFACE; DATA ANALYSIS; DATA BASE; DATA PROCESSING; DRIVERDB; GENE; GENE MUTATION; NEOPLASM; PRIORITY JOURNAL; EXOME; HIGH THROUGHPUT SEQUENCING; HUMAN; INTERNET; MOLECULAR GENETICS; MUTATION; NUCLEIC ACID DATABASE; TUMOR GENE; BIOINFORMATICS; BIOTECHNOLOGY; CANCER GENETICS; COPY NUMBER VARIATION; DRIVER GENE; DRIVERDB DATABASE; EXOME SEQUENCING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC PROCEDURES; SEQUENCE DATABASE; SINGLE NUCLEOTIDE POLYMORPHISM;

DATABASES, NUCLEIC ACID; EXOME; GENES, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INTERNET; MOLECULAR SEQUENCE ANNOTATION; MUTATION;

EID: 84891757926     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1025     Document Type: Article

References (64)

1. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr and Kinzler, K.W. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
2. Shyr, D. and Liu, Q. (2013) Next generation sequencing in cancer research and clinical application. Biol. Proced. Online, 15, 4.
3. Stratton, M.R., Campbell, P.J. and Futreal, P.A. (2009) The cancer genome. Nature, 458, 719-724.
4. Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S., Karchin, R., Kinzler, K.W., Vogelstein, B. and Nowak, M.A. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA, 107, 18545-18550.
5. Gnad, F., Baucom, A., Mukhyala, K., Manning, G. and Zhang, Z. (2013) Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics, 14(Suppl. 3), S7.
6. Carter, H., Chen, S., Isik, L., Tyekucheva, S., Velculescu, V.E., Kinzler, K.W., Vogelstein, B. and Karchin, R. (2009) Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res., 69, 6660-6667.
7. Zhao, H., Yang, Y., Lin, H., Zhang, X., Mort, M., Copper, D.N., Liu, Y. and Zhou, Y. (2013) DDIG-in: discriminating between disease-associated and neutral non-frameshifting micro-indels. Genome Biol., 14, R23.
8. Li, M.X., Kwan, J.S., Bao, S.Y., Yang, W., Ho, S.L., Song, Y.Q. and Sham, P.C. (2013) Predicting mendelian disease-causing non-synonymous single nucleotide variants in exome sequencing studies. PLoS Genet., 9, e1003143.
9. Lawrence, M.S., Stojanov, P., Polak, P., Kryukov, G.V., Cibulskis, K., Sivachenko, A., Carter, S.L., Stewart, C., Mermel, C.H., Roberts, S.A. et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 499, 214-218.
10. Dees, N.D., Zhang, Q., Kandoth, C., Wendl, M.C., Schierding, W., Koboldt, D.C., Mooney, T.B., Callaway, M.B., Dooling, D., Mardis, E.R. et al. (2012) MuSiC: identifying mutational significance in cancer genomes. Genome Res., 22, 1589-1598.
11. Youn, A. and Simon, R. (2011) Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics, 27, 175-181.
12. Gonzalez-Perez, A. and Lopez-Bigas, N. (2012) Functional impact bias reveals cancer drivers. Nucleic Acids Res., 40, e169.
13. Reimand, J. and Bader, G.D. (2013) Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers. Mol. Syst. Biol., 9, 637.
14. Michaelson, J.J., Shi, Y., Gujral, M., Zheng, H., Malhotra, D., Jin, X., Jian, M., Liu, G., Greer, D., Bhandari, A. et al. (2012) Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell, 151, 1431-1442.
15. Nik-Zainal, S., Alexandrov, L.B., Wedge, D.C., Van Loo, P., Greenman, C.D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L.A. et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell, 149, 979-993.
16. Zhao, J., Zhang, S., Wu, L.Y. and Zhang, X.S. (2012) Efficient methods for identifying mutated driver pathways in cancer. Bioinformatics, 28, 2940-2947.
17. Vandin, F., Upfal, E. and Raphael, B.J. (2012) De novo discovery of mutated driver pathways in cancer. Genome Res., 22, 375-385.
18. Leiserson, M.D., Blokh, D., Sharan, R. and Raphael, B.J. (2013) Simultaneous identification of multiple driver pathways in cancer. PLoS Comput. Biol., 9, e1003054.
19. Ciriello, G., Cerami, E., Sander, C. and Schultz, N. (2012) Mutual exclusivity analysis identifies oncogenic network modules. Genome Res., 22, 398-406.
20. Cerami, E., Demir, E., Schultz, N., Taylor, B.S. and Sander, C. (2010) Automated network analysis identifies core pathways in glioblastoma. PLoS ONE, 5, e8918.
21. Bashashati, A., Haffari, G., Ding, J., Ha, G., Lui, K., Rosner, J., Huntsman, D.G., Caldas, C., Aparicio, S.A. and Shah, S.P. (2012) DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer. Genome Biol., 13, R124.
22. Trifonov, V., Pasqualucci, L., Dalla Favera, R. and Rabadan, R. (2013) MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples. BMC Syst. Biol., 7, 25.
23. Dand, N., Sprengel, F., Ahlers, V. and Schlitt, T. (2013) BioGranat-IG: a network analysis tool to suggest mechanisms of genetic heterogeneity from exome-sequencing data. Bioinformatics, 29, 733-741.
24. Miller, C.A., Settle, S.H., Sulman, E.P., Aldape, K.D. and Milosavljevic, A. (2011) Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. BMC Med. Genomics, 4, 34.
25. Vandin, F., Upfal, E. and Raphael, B.J. (2012) Finding driver pathways in cancer: models and algorithms. Algorithm. Mol. Biol., 7, 23.
26. Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M. and Sirotkin, K. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res., 29, 308-311.
27. Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T. and McVean, G.A. (2012) An integrated map of genetic variation from 1, 092 human genomes. Nature, 491, 56-65.
28. Forbes, S.A., Bindal, N., Bamford, S., Cole, C., Kok, C.Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A. et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res., 39, D945-D950.
29. Tennessen, J.A., Bigham, A.W., O'Connor, T.D., Fu, W., Kenny, E.E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G. et al. (2012) Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science, 337, 64-69.
30. Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S. and Manolio, T.A. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA, 106, 9362-9367.
31. Cooper, D.N., Stenson, P.D. and Chuzhanova, N.A. (2006) The Human Gene Mutation Database (HGMD) and its exploitation in the study of mutational mechanisms. Curr. Protoc. Bioinformatics, Chapter 1, Unit 1 13.
32. Cingolani, P., Platts, A., Wang le, L., Coon, M., Nguyen, T., Wang, L., Land, S.J., Lu, X. and Ruden, D.M. (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly, 6, 80-92.
33. McLaren, W., Pritchard, B., Rios, D., Chen, Y., Flicek, P. and Cunningham, F. (2010) Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics, 26, 2069-2070.
34. Ng, P.C. and Henikoff, S. (2001) Predicting deleterious amino acid substitutions. Genome Res., 11, 863-874.
35. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
36. Gonzalez-Perez, A. and Lopez-Bigas, N. (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am. J. Hum. Genet., 88, 440-449.
37. Chun, S. and Fay, J.C. (2009) Identification of deleterious mutations within three human genomes. Genome Res., 19, 1553-1561.
38. Shihab, H.A., Gough, J., Cooper, D.N., Day, I.N. and Gaunt, T.R. (2013) Predicting the functional consequences of cancer-associated amino acid substitutions. Bioinformatics, 29, 1504-1510.
39. Reva, B., Antipin, Y. and Sander, C. (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res., 39, e118.
40. Schwarz, J.M., Rodelsperger, C., Schuelke, M. and Seelow, D. (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods, 7, 575-576.
41. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. and Tanabe, M. (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res., 40, D109-D114.
42. Schaefer, C.F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T. and Buetow, K.H. (2009) PID: the Pathway Interaction Database. Nucleic Acids Res., 37, D674-D679.
43. Croft, D., O'Kelly, G., Wu, G., Haw, R., Gillespie, M., Matthews, L., Caudy, M., Garapati, P., Gopinath, G., Jassal, B. et al. (2011) Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res., 39, D691-D697.
44. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
45. Kerrien, S., Aranda, B., Breuza, L., Bridge, A., Broackes-Carter, F., Chen, C., Duesbury, M., Dumousseau, M., Feuermann, M., Hinz, U. et al. (2012) The IntAct molecular interaction database in 2012. Nucleic Acids Res., 40, D841-D846.
46. Chatr-Aryamontri, A., Breitkreutz, B.J., Heinicke, S., Boucher, L., Winter, A., Stark, C., Nixon, J., Ramage, L., Kolas, N., O'Donnell, L. et al. (2013) The BioGRID interaction database: 2013 update. Nucleic Acids Res., 41, D816-D823.
47. Razick, S., Magklaras, G. and Donaldson, I.M. (2008) iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinformatics, 9, 405.
48. Lopes, C.T., Franz, M., Kazi, F., Donaldson, S.L., Morris, Q. and Bader, G.D. (2010) Cytoscape Web: an interactive web-based network browser. Bioinformatics, 26, 2347-2348.
49. Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D., Miller, C.R., Ding, L., Golub, T., Mesirov, J.P. et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110.
50. Cancer Genome Atlas Research Network. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
51. Schwartzentruber, J., Korshunov, A., Liu, X.Y., Jones, D.T., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A.M., Quang, D.A., Tonjes, M. et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482, 226-231.
52. Pugh, T.J., Morozova, O., Attiyeh, E.F., Asgharzadeh, S., Wei, J.S., Auclair, D., Carter, S.L., Cibulskis, K., Hanna, M., Kiezun, A. et al. (2013) The genetic landscape of high-risk neuroblastoma. Nat. Genet., 45, 279-284.
53. Cheung, N.K. and Dyer, M.A. (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat. Rev. Cancer, 13, 397-411.
54. Rashid, M.U., Muhammad, N., Faisal, S., Amin, A. and Hamann, U. (2013) Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan. BMC Cancer, 13, 312.
55. Yu, K., Ganesan, K., Tan, L.K., Laban, M., Wu, J., Zhao, X.D., Li, H., Leung, C.H., Zhu, Y., Wei, C.L. et al. (2008) A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers. PLoS Genet., 4, e1000129.
56. Maekawa, R., Sato, S., Yamagata, Y., Asada, H., Tamura, I., Lee, L., Okada, M., Tamura, H., Takaki, E., Nakai, A. et al. (2013) Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas. PLoS ONE, 8, e66632.
57. Gardina, P.J., Clark, T.A., Shimada, B., Staples, M.K., Yang, Q., Veitch, J., Schweitzer, A., Awad, T., Sugnet, C., Dee, S. et al. (2006) Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics, 7, 325.
58. Arafat, H., Lazar, M., Salem, K., Chipitsyna, G., Gong, Q., Pan, T.C., Zhang, R.Z., Yeo, C.J. and Chu, M.L. (2011) Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer. Surgery, 150, 306-315.
59. Vivanco, I., Robins, H.I., Rohle, D., Campos, C., Grommes, C., Nghiemphu, P.L., Kubek, S., Oldrini, B., Chheda, M.G., Yannuzzi, N. et al. (2012) Differential sensitivity of glioma-versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Disc., 2, 458-471.
60. Small, D. (2006) FLT3 mutations: biology and treatment. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 178-184.
61. Gonzalez-Perez, A., Deu-Pons, J. and Lopez-Bigas, N. (2012) Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation. Genome Med., 4, 89.
62. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Disc., 2, 401-404.
63. Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E. et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal., 6, pl1.
64. Gundem, G., Perez-Llamas, C., Jene-Sanz, A., Kedzierska, A., Islam, A., Deu-Pons, J., Furney, S.J. and Lopez-Bigas, N. (2010) IntOGen: integration and data mining of multidimensional oncogenomic data. Nat. Methods, 7, 92-93.